Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer. - Wikidata - wikimedia - TriplyDB

Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer.

Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer.

http://www.wikidata.org/entity/Q37382687

about

NFκB signalling is upregulated in a subset of castrate-resistant prostate cancer patients and correlates with disease progression Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro Correlation of NF-kappaB signal pathway with tumor metastasis of human head and neck squamous cell carcinoma.A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF-kappaB signaling.Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization NF-κB addiction and its role in cancer: 'one size does not fit all'.Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor κB (NF-κB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling.Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcino HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma.Characterization of key transcription factors as molecular signatures of HPV-positive and HPV-negative oral cancers.Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma Glycogen synthase kinase 3 beta: can it be a target for oral cancer.Inhibitory kappa B Kinases as targets for pharmacological regulation.A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.Interventions for the management of oral lichen planus: a review of the conventional and novel therapies.PPM1A is a RelA phosphatase with tumor suppressor-like activity.Epithelial-mesenchymal transition and mesenchymal-epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells.Virally delivered, constitutively active NFκB improves survival of injured retinal ganglion cells.Combination of EPA with Carotenoids and Polyphenol Synergistically Attenuated the Transformation of Microglia to M1 Phenotype Via Inhibition of NF-κB.Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma.Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy.

P2860

Q28390763-BFCA6E66-44F3-4CA6-B204-6E95B42DEB98 Q28477081-7D753586-E7B7-463B-8E0C-79782686851F Q33661096-78E48968-9B7C-4EE0-BBE8-DE9F32733DB9 Q34121641-4B4AFFE5-664C-4833-A42B-42566B30AD74 Q34163076-3A8212FB-ECA6-4830-A960-636EA42DB30C Q34397827-82CF4CAE-BC75-4AD7-BB71-A0FA4CF92E99 Q35120893-1A1B3284-F3C6-4CE0-874D-6DA42979A6D0 Q35377816-88575BBE-1C02-40D2-887B-91B4650CB4BA Q36201954-F31CF8B2-B698-4D55-A66F-272E4B53F883 Q36947423-26AD37E4-A210-4465-8D33-11575DC3B85D Q37060950-76B359CD-E69E-4B02-96CE-1ADECC8D26AD Q37693385-079C0570-1F4A-4F53-AD6C-FAA13B3B210C Q37723806-971332AF-1334-472D-8C2E-95D0A1E8CDC1 Q37727209-167E7622-E4AB-4302-8859-1FACD37A42BF Q37764097-CC46BFF1-BA3B-4E7F-84F5-EFD38501C641 Q37907354-23A8DF79-ECBC-48A2-BD07-B8F733478B0E Q38834978-E595D62F-F61F-4131-92FE-246731C73898 Q39038652-CBA089CF-AAAF-4F3D-BD62-1294CDD8B50D Q39132976-E4578F4F-4F89-45A3-9310-0A606D1CDD0E Q39355787-F1024F78-2CE9-46C8-920D-2AA341E12BBF Q39450768-D1326492-7039-4B5D-8EC5-BFA30BA84237 Q40105742-C51F44A2-F158-42C4-BC95-8FD9ED679194 Q43117102-A777D5F8-6D9F-476F-8275-B91CC83C4DCD Q43169264-A638D169-795E-4147-B4E6-291F929EADD2

P2860

Nuclear NF-kappaB p65 phosphorylation at serine 276 by protein kinase A contributes to the malignant phenotype of head and neck cancer.

http://www.wikidata.org/entity/Q37382687

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nuclear NF-kappaB p65 phosphor ...... otype of head and neck cancer.

@en

Nuclear NF-kappaB p65 phosphor ...... otype of head and neck cancer.

@nl

type

label

Nuclear NF-kappaB p65 phosphor ...... otype of head and neck cancer.

@en

Nuclear NF-kappaB p65 phosphor ...... otype of head and neck cancer.

@nl

prefLabel

Nuclear NF-kappaB p65 phosphor ...... otype of head and neck cancer.

@en

Nuclear NF-kappaB p65 phosphor ...... otype of head and neck cancer.

@nl

P1433

Q37382687-88B57977-E394-4D2B-8ED0-31E4D2534E63

P1476

Q37382687-17F7F68E-AA8F-4488-B912-7F153069C0F8

P2093

Q37382687-316E7814-1177-48C8-B003-0A4B76163FEB

Q37382687-3D62DC9C-2757-4A2E-8FF8-FF1FFB511003

Q37382687-8059835F-E22C-4E7B-BE91-5E85515AE333

Q37382687-8D7220BB-E565-4195-BE77-534E657A60C7

P2860

Q37382687-00163A4D-4C46-41FB-813C-34BA0D80BE24

Q37382687-02590171-009B-4FF3-AE0A-D234F3304F5E

Q37382687-0CB9D93D-DA79-4F81-8FE8-C82478BE71C8

Q37382687-0DB9A7D0-7B48-4222-BD0F-A0E7DDC9E864

Q37382687-14E4F2A4-12D5-4135-B0A8-00ABB6902A4E

Q37382687-14FCD27E-7E62-4ED3-886C-5970C84974EF

Q37382687-18F52D05-18AE-4993-B39E-6636F7CBEBE5

Q37382687-2933FC81-A9C4-4778-BE07-47FD4878C642

Q37382687-2ABB6C5F-5E63-4328-A6A7-88AE0F5121B8

Q37382687-309CD48B-C3A1-4C90-9DF2-8DF367158637

P304

Q37382687-32B9E81E-6020-49A3-8C9F-8F2B70C240CC

P31

Q37382687-E4809B5F-4259-451D-817A-3D5B6B3C2350

P356

Q37382687-6A53409E-ED1F-4D3C-B87C-D159A346ABCA

P407

Q37382687-16324933-CD5F-4974-8F1A-65B01FD52C37

P433

Q37382687-5017C41F-164D-4121-A8F2-9A8EC649F462

P478

Q37382687-F8028AEC-A08A-4678-992F-E6602EA01030

P50

Q37382687-B3485D4D-A353-4715-8DAD-75CFE493B54B

P577

Q37382687-5C57DEB5-344B-4FB7-8F40-546CACD2E631

P698

Q37382687-ADAD97A8-F889-4491-B0E1-25321FCC0A64

P921

Q37382687-7D53B3D1-294A-41D1-9BB1-1521D1A2FBC1

P932

Q37382687-C48A775B-C14D-417E-9895-8ACAEB302F19

P356

1078-0432.CCR-09-1352

P1433

Clinical Cancer Research

P1476

Nuclear NF-kappaB p65 phosphor ...... notype of head and neck cancer

@en

P2093

Carter Van Waes

http://www.w3.org/2001/XMLSchema#string

Pattatheyil Arun

http://www.w3.org/2001/XMLSchema#string

Reza Ehsanian

http://www.w3.org/2001/XMLSchema#string

Zhong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain

Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)

Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity

Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway

The NF-kappa B and I kappa B proteins: new discoveries and insights

The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis

RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes

Inhibition of cAMP-dependent protein kinase A: a novel cyclo-oxygenase-independent effect of non-steroidal anti-inflammatory drugs in adipocytes

Relative non-steroidal anti-inflammatory drug (NSAID) antiproliferative activity is mediated through p21-induced G1 arrest and E2F inhibition

Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma

P304

5974-5984

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-1352

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19789307

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

2760015

http://www.w3.org/2001/XMLSchema#string